In addition, fetuin-A mRNA expression is elevated in individuals with NASH/MASH compared to those with simple fatty liver [87], where it negatively regulates adiponectin, thereby impairing its insulin-sensitizing and anti-inflammatory effects. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatohepatitis.